Shares of MediPharm Labs Corp. (TSE:LABS – Get Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as C$0.06 and last traded at C$0.06, with a volume of 178824 shares trading hands. The stock had previously closed at C$0.07.
MediPharm Labs Stock Performance
The company has a current ratio of 3.11, a quick ratio of 3.10 and a debt-to-equity ratio of 5.90. The stock has a market capitalization of C$24.66 million, a P/E ratio of -1.50 and a beta of 0.88. The company’s fifty day simple moving average is C$0.07 and its 200 day simple moving average is C$0.07.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Featured Articles
- Five stocks we like better than MediPharm Labs
- Upcoming IPO Stock Lockup Period, Explained
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- What is the S&P 500 and How It is Distinct from Other Indexes
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Short Selling: How to Short a Stock
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
